Reveals a new assay for monitoring mycophenolic acid in plasma, suggesting improved management strategies.
Mycophenolic acid (MPA), an immunosuppressive metabolite of Penicillium fungi with a narrow therapeutic window, poses significant clinicals risks of toxicity or transplant rejection if its concentration is not strictly controlled....
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: